Business Description
Arecor Therapeutics is a UK-based clinical-stage biotech company focused on improving existing medicines and creating new treatments for people with diabetes and other conditions. Using its proprietary Arestat platform, the company reformulates therapeutic products to make them more effective, working both independently and in partnership with other pharmaceutical firms. Its pipeline includes faster-acting and more concentrated insulin formulations, a treatment for severe low blood sugar episodes, and collaborative projects exploring oral GLP-1 therapies and insulins designed for implantable pumps.
